Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Other2

Role Distribution

Principal Investigator1
Other Roles1
PI Rate50%

Activity Timeline

Clinical Trials (2)

NCT06577961Phase 1/2Not Yet Recruiting
Vorolanib Combined With Cadonilimab in the Treatment of Untreated Advanced RCC Patients
Kidney CancerRCCRenal Cell Carcinoma
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT06577961Phase 1/2PrincipalInvestigator

Vorolanib Combined With Cadonilimab in the Treatment of Untreated Advanced RCC Patients

Kidney CancerRCCRenal Cell Carcinoma
Not Yet Recruiting
NCT07440901StudyChair

Remodeling of MHC-related Immune Microenvironment in MIBC After Neoadjuvant Therapy

Muscle-invasive Bladder Cancer
Not Yet Recruiting

All 2 trials loaded